Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05615844 · ClinicalTrials.gov registry record · Phase 3

Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy

A Phase 3 study of Open tíbia Fracture, sponsored by University of Maryland, Baltimore.

Recruiting
Registry status
Phase 3
Development phase
312
Enrollment target
20
Study locations

NCT05615844 is a Phase 3 study of Open tíbia Fracture that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 312 participants. The trial reports 20 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05615844, a Phase 3 study of Open tíbia Fracture, is actively recruiting participants, sponsored by University of Maryland, Baltimore.

RECRUITING
Registry status
Phase 3
Development phase
312 participants
Enrollment target
20
Study locations

Study Summary

The Beads vs Vac trial is a multi-centre randomized controlled trial of 312 participants with a severe open tibia fracture requiring multiple irrigation and debridement surgeries. Eligible participants will be randomized to receive either an antibiotic bead pouch or negative pressure wound therapy (NPWT) for their temporary open fracture wound management. Outcomes will be assessed at 6 weeks, 3 months, and 6 months post-surgery. The primary outcome will be a composite outcome to evaluate clinical status six months after randomization. Components of the composite outcome will be hierarchically assessed in the following order: 1) all-cause mortality, 2) injury-related amputation of the lower extremity, 3) unplanned reoperation to manage wound complications, infection, or delayed fracture healing, and 4) clinical fracture healing as assessed using the Functional IndeX for Trauma (FIX-IT) instrument. The secondary outcomes will independently assess the four components of the primary outcome. This is a Phase III trial.

Conditions Studied

Interventions

  • DRUG Antibiotic Cement Bead Pouch
  • DEVICE Negative Pressure Wound Therapy

Study Locations (20)

California

  • University of California, Davis - Davis
  • University of Southern California - Los Angeles
  • Cedars-Sinai Medical Center - Los Angeles
  • University of California, Irvine - Orange

Florida

  • University of Florida - Gainesville
  • University of Miami - Miami

Maryland

  • University of Maryland, R Adams Cowley Shock Trauma Center - Baltimore
  • University of Maryland Capital Region Health - Largo

Ohio

  • University of Cincinnati - Cincinnati
  • Bon Secours Mercy Health - Cincinnati

Arizona

  • Dignity Health Chandler Regional Medical Center - Chandler

Connecticut

  • Yale University - New Haven

Indiana

  • Indiana University - Indianapolis

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 312 participants
Start Date 2023-11-05
Est. Completion 2027-10-01
Phase Phase 3

Sponsor

University of Maryland, Baltimore

560 total trials

What the Registry Record Tells You About NCT05615844

The ClinicalTrials.gov registry entry for NCT05615844 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 312 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Open tíbia Fracture appearing as the primary indexed condition, and to 2 interventions - of which Antibiotic Cement Bead Pouch is the first listed.

NCT05615844 reports 20 study locations spanning 14 distinct geographic areas - top geographies include California, Florida, Maryland.

Frequently Asked Questions

What is clinical trial NCT05615844 about?

NCT05615844 is a clinical study titled "Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy". The Beads vs Vac trial is a multi-centre randomized controlled trial of 312 participants with a severe open tibia fracture requiring multiple irrigation and debridement surgeries. Eligible participants will be randomized to receive either an antibiotic bead pouch or negative pressure wound therapy (...

What is the current status of trial NCT05615844?

This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 312 participants. The study started on 2023-11-05. Estimated completion is 2027-10-01.

What conditions does trial NCT05615844 study?

This clinical trial studies the following conditions: Open tíbia Fracture.

What interventions are being tested in trial NCT05615844?

The interventions under investigation include: Antibiotic Cement Bead Pouch (DRUG), Negative Pressure Wound Therapy (DEVICE).

Who is sponsoring clinical trial NCT05615844?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05615844 being conducted?

This trial has 20 study locations across Arizona, California, Connecticut, Florida, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Open tíbia Fracture

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.